Navigation Links
Personalized in Medical Technology

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

... St. Jude study shows personalized chemotherapy can improve cure rate and avoid the ... can be successfully treated using a carefully personalized chemotherapy regimen without cranial radiation, ... Campana said. St. Jude investigators applied personalized therapy based on molecular genetics of ALL, ...

FDA Advisory Panel Recommends Approval of the SEDASYS(R) System

... SEDASYS(R) System, the first computer-assisted personalized sedation (CAPS) system, integrates drug delivery and patient monitoring to enable propofol sedation personalized to each patient's needs. The Anesthesiology ... SEDASYS(R) System is the first computer-assisted personalized sedation (CAPS) system designed for ...

Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis

... Inc. (NYSE Amex: ILI ), is a genetics-focused personalized health company that develops preventive consumer ... and genetic tests for sale to the emerging personalized health market. Focused on the future of health ... regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent ...

Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival

... DCVax(R)-Brain is a groundbreaking personalized vaccine that takes a patient's own master immune ... process produces several years of personalized vaccine for a patient, making DCVax(R)-Brain an ... 573). As noted above, DCVax(R)-Brain is a personalized immunotherapy designed to stimulate a patient's ...

Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain

... analysis. DCVax(R)-Brain is a groundbreaking personalized vaccine that takes a patient's own immune cells ... manufacturing process produces several years of personalized vaccine for a patient, making DCVax(R)-Brain an ... patients. As noted above, DCVax(R)-Brain is a personalized immunotherapy designed to stimulate a patient's ...

New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS)

... from Saladax Biomedical, called 5-FU personalized Chemotherapy Management (PCM(R)), performed as ... 5-FU in the blood will enable simplified, personalized dose management with the goal of minimizing ... BSA compared with patients who had doses personalized according to 5-FU blood plasma levels. The study ...

CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting

... being treated by the rEEG guided medications personalized to their own brain function. We would never have ... this study in which he documented the benefits of personalized medication selection based on analysis of brain ... and their physicians can hope for a truly personalized medicine approach. We are proud to recognize Dr. ...

Studies Point to Benefits of Personalized Chemotherapy Dose Management in Colorectal Cancer

... Recently published studies indicate that personalized chemotherapy dose management -- measuring drug ... patients whose dose of 5-fluorouracil (5-FU) was personalized based on results of regular blood tests ... patients' height and weight. In the JCO study, personalized dosing was based on blood tests to measure the ...

Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients

... Copley Place and Hynes Convention Center. personalized care is an integrative process of tailoring care ... Framingham, MA, will present data pertaining to personalized care, its benefits and future impact on heart and ... new and original information on biomarkers and personalized care in lectures given at ISHLT will offer a ...

Vanda Pharmaceuticals Submits Iloperidone New Drug Application

... to usher the field of psychiatry into an era of personalized medicine," said Mihael H. Polymeropoulos, M.D., ... College of Medicine. First Step Towards personalized Medicine "The application of personalized medicine in schizophrenia is significant because ...

Personalized Medicine - The Genomic Revolution in Cardiac Care

... around the growing forces of genomics and personalized medicine in cardiology. This symposium ... examine the issues and stimulate new ideas around personalized medicine as it relates to personalized cardiovascular care. Researchers, cardiologists, ...

New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD

... http://www.brainclinics.com Brainclinics is specialized in personalized Medicine, applied Neuroscience and diagnostics of Brain related disorders. ... in order to achieve more efficacious clinical outcomes (also called personalized Medicine). ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... which drugs work for which individuals with diabetes will provide a more personalized approach which can help improve care for people with diabetes and ... chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice ...

Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women

... of my cancer returning." Multiple Studies Highlight Application of personalized Medicine in Oncology Setting Additionally, Genomic Health, in ... Steve Shak, M.D., chief medical officer of Genomic Health. "As a leader in personalized medicine, we are committed to further increasing the clinical utility of ...

Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects

... in the current issue of the Future Medicine Group (London) journal personalized Medicine (Vol. 5, No. 6, pp. 579-587, 2008) are helping to point the way ... Genomas(R) Inc. is a biomedical company advancing DNA-guided medicine and personalized healthcare. The company develops revolutionary PhyzioType(TM) Systems for ...

Agendia's MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines

... patient's risk profile, ultimately providing a significant benefit of more personalized medicine. The Dutch guideline committee also encouraged physicians to ... the company collaborates with pharma companies to develop highly effective personalized drugs in the area of oncology. Agendia is based in Huntington Beach, ...

Agendia Launches TargetPrint(R) for Breast Cancer Patients

... Identification for Targeted Therapies That Ensure Benefits of personalized Treatment HUNTINGTON BEACH, Calif., and AMSTERDAM, Netherlands, Sept. ... the company collaborates with pharma companies to develop highly effective personalized drugs in the area of oncology. Agendia is based in Huntington Beach, ...

New Genes Found for Inflammatory Bowel Disease in Children

... - Finding May Refine Drug Targets for personalized Treatments - PHILADELPHIA, Aug. 31 /PRNewswire-USNewswire/ -- ... in this complex, chronic disease, we are building the foundation for personalized treatments tailored to a patient's genetic profile," said co-first author ...

Saladax Biomedical's 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU

... majority of patients are either over-dosed or in most cases, under-dosed. personalized 5-FU dosing allows us to substantially reduce severe toxicity while ... drugs to become the standard of care in treating cancer patients. With personalized Chemotherapy Management (PCM), oncologists will be able to adjust the ...

Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate

... predictive preclinical platform and tumor specific data to physicians for personalized patient care and to companies for evaluation of oncology drugs and drug ... accelerating development and valuation of oncology drugs, and advancing personalized treatment with a goal to improve the lives of cancer patients globally. ...

TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)

... potential of this sequential regimen, in an effort to achieve a personalized cancer vaccination in vivo. Seven patients with chemo-resistant cancer, ... constructs employed are relatively safe; and (3) the potential for a personalized cancer vaccination using this sequential gene transfer approach is now a ...

Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service

... that they have teamed up to offer patients and physicians the largest personalized cancer clinical trial matching and referral service in the United States. ... looking for clinical trials." "EmergingMed is committed to providing personalized services to patients who are exploring treatment options," remarked ...

Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs

... predictive preclinical platform and tumor specific data to physicians for personalized patient care. In the course of this process, this permits the Company to ... accelerating development and valuation of oncology drugs, and advancing personalized treatment with a goal to improve the lives of cancer patients globally. ...

Intra-Cellular Therapies Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs

... between activity at dopamine and serotonin receptors will allow a personalized approach to patient treatment for schizophrenia providing an ability to 'dial-in' the optimal D2 receptor occupancy on an individual basis. This personalized approach will allow physicians to tailor doses to achieve optimal ...

Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting

... 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a provider of personalized diagnostic services, announced today at the ASH Meeting in Atlanta, ... is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and ...

DNA Helps Reunite Children With Their Families

... discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had ...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... melanoma patients with documented metastatic disease," said Dr. Dillman. "This study is extremely encouraging and shows the potential these types of personalized cancer vaccines have for patients diagnosed with metastatic melanoma." About Hoag Cancer Center Hoag Cancer Center is accredited as a ...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... of achieving improved anti-tumor effectiveness by careful selection of patients who are most likely to benefit, and is consistent with our focus on personalized approaches to cancer drug development," said Jack Singer, M.D., Chief Medical Officer at CTI. "This may be of particular importance in patients with ...

UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201

... development collaboration with BiPar on this important potential new therapy," said Steve Smith, vice president and general manager of Research and personalized Science for US Oncology Research. "We are eager to leverage the US Oncology Research network to support the study." Patients targeted for ...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... whom we should screen intensively for AF and then prescribe the drugs most suited to the cause of a particular patient's disease. This is the sort of personalized medicine that genetics is enabling - individualized care that may mean not only better outcomes but significant potential savings to the healthcare ...

Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris

... Sirius Genomics is a drug-enabling company that develops pharmacogenomic (PGx) diagnostics that lead to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The Company correlates patient genetics with ...

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

... Clinical and Regulatory Affairs of Accumetrics, Inc. "Once complete, GRAVITAS will be the largest multi-center clinical trial that links testing with personalized medicine and improved patient outcomes. We continue our commitment to ensuring that the VerifyNow System is shown to be an integral tool in ...

/C O R R E C T I O N -- Agendia B.V./

... the Annals of Oncology: http://annonc.oxfordjournals.org/cgi/content/full/mdp322v1 About Agendia Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics ...

West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial

... California. ABOUT CORVENTIS Corventis, Inc. is a pioneer in wireless cardiovascular solutions. The company's technology enables global personalized patient care by providing clinicians with actionable diagnoses for early detection, prevention and treatment. Corventis is funded by prominent ...

Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations

... the Annals of Oncology: http://annonc.oxfordjournals.org/cgi/content/full/mdp322v1 About Agendia Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics ...

CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy

... to produce breakthroughs in research and medical care. With a focus on addressing customer needs coupled to a commitment to advancing the field of personalized medicine, CRi helps scientists and clinicians extract new disease-specific information from biological samples in the physiological, morphological, ...

Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW

... novel pharmaceutical and diagnostic products to help physicians individualize patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and intends to apply these principles to oncology. Its strategy includes the ...

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

... unique expertise in genomic profiling and proprietary algorithms, bioTheranostics provides innovative tests to the oncology community that help drive personalized treatment. The company operates a CLIA-certified, CAP-accredited diagnostic service laboratory in San Diego, CA to perform its proprietary molecular ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -a key element in reforming America's health care system. Medco ...

Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009

... It is the first irreversible EGFR-TKI (tyrosine kinase inhibitor) to reach Phase III for third/fourth-line NSCLC.(4) In the emerging era of personalized cancer medicine, Boehringer Ingelheim is one of the first companies to prospectively identify appropriate patients for clinical trials based on ...
Other Contents
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin ... deployed, innovative test solutions for military, aerospace, and ... version of its successful TS-900 PXI semiconductor ... and features of high-end systems to customers at ... value compared to traditional ATE. ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
(Date:12/25/2014)... December 26, 2014 “Every three months the ... changes. A-line sweetheart evening dress will be one of the ... manager of Yunx.co.uk says. Today, the company releases 26 A-line ... up to 80% off. , “We are trying our ... style with our latest designs. Along with affordable prices, we ...
(Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International founder ... an 8 year battle with breast cancer. , ... her home in Woodland Hills California after an 8 ... , As the founder and volunteer President of ... championed many of today's greatest breakthroughs in restoring and ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... children with complex chronic illnesses can receive effective, less expensive ... with easy access to a team of dedicated health care ... to become seriously ill and need either hospitalization or a ... an enhanced medical home clinic at the University of Texas ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
Other TagsOther Tags